Prevalence of metabolic associated fatty liver disease is increasing
CHICAGO—The percent of metabolic associated fatty liver disease (MAFLD), the leading global cause of liver disease, is increasing in U.S. adults, according to a study presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Mexican Americans consistently had the highest percentage of MAFLD, especially in 2018, although the prevalence of increase was higher among Whites, the study found.
MAFLD, previously known as non-alcoholic fatty liver disease (NAFLD), is fast becoming the most common indication ...











